Genpact vs Hinge Health
Genpact (G) and Hinge Health (HNGE) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $6.94B
- Last close
- $41.50
- 12 months
- −5.1%
- Market value
- $8.54B
- Last close
- $105.78
- 12 months
- +133.2%
At a glance
- The biggest part of Genpact's revenue is High Tech and Manufacturing, 39% of the total in its last annual report.
- Genpact and Hinge Health are close in size by market value ($6.9B and $8.5B).
- Over the last 12 months Genpact's share price moved −5.1% and Hinge Health's +133.2%; against the S&P 500 that is −10.8 points and +127.5 points.
- In their last fiscal years Genpact kept 10.9% of revenue as net income and Hinge Health -89.9%.
- In the last 90 days insiders reported 0 open-market purchases at Genpact and 0 at Hinge Health; members of Congress disclosed 0 trades in Genpact and 0 in Hinge Health.
- Next results: Genpact Feb 3, 2027, Hinge Health not announced.
How each one makes money: Genpact revenue
Share prices on one chart
Genpact and Hinge Health, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Genpact GNYSE · Data Processing & Outsourced Services | Hinge Health HNGENYSE · Services-Computer Processing & Data Preparation | |
|---|---|---|
| Size and profitability | ||
| Market value | $6.94B | $8.54B |
| Revenue, last fiscal year | $5.08B | $588M |
| Net income, last fiscal year | $552M | −$528M |
| Net marginNet income as a share of revenue | 10.9% | -89.9% |
| Free cash flow | $735M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is Genpact different from Hinge Health?
Genpact (G) is in Data Processing & Outsourced Services on NYSE, with $5.08B of revenue in its last fiscal year and a net margin of 10.9%. Hinge Health (HNGE) is in Services-Computer Processing & Data Preparation on NYSE, with $588M of revenue in its last fiscal year and a net margin of -89.9%. The biggest part of Genpact's revenue is High Tech and Manufacturing, 39% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Genpact and Hinge Health compare in size?
Hinge Health has the larger market value: Genpact $6.94B and Hinge Health $8.54B, at the last close.
Whose share price rose more over the last 12 months, G or HNGE?
Over the last 12 months Genpact moved −5.1% and Hinge Health +133.2%. Past price moves say nothing about the future.
Which has had more insider buying, Genpact or Hinge Health?
Since 2006, Genpact insiders reported 13 open-market purchases against 0 for Hinge Health. These are counts of what was filed, not a view on either stock.
Do members of Congress trade G or HNGE?
In the last 12 months, members of Congress disclosed 0 trades in Genpact (G) and 0 in Hinge Health (HNGE).
When did insiders last buy G and HNGE?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Genpact pageHinge Health pageRare insider trades this weekAll comparisons
https://oqro.io/compare/g-vs-hnge

